Founded by world-leading scientists, our team has the tenacity to pursue our ultimate peak – creating new therapies for heart disease for the patients and families who need them.
Tenaya is shaping the future of heart disease treatment driven by a bold mission: to discover, develop, and deliver curative therapies that address the underlying drivers of disease, including rare genetic disorders as well as more prevalent heart conditions.
We are revolutionizing the treatment of heart disease through three interrelated approaches: Gene Therapy, Cardiac Regeneration and Precision Medicine.
Tenaya Therapeutics Secures $106 Million in Series C Funding to Accelerate Pipeline of Potentially Curative Therapies for Heart Disease
- Series C round led by RTW Investments, LP; RA Capital Management; Fidelity Management & Research Company; and funds and accounts advised by T. Rowe Price Associates, Inc.; and joined by existing investors including The Column Group,
Navigating the Complexities of AAV Scale-Up and Manufacturing
Tenaya’s senior vice president of manufacturing, Kee-Hong Kim, Ph.D., spoke with John Sterling, editor of Genetic Engineering & Biotechnology News in an executive roundtable interview to discuss the challenges and complexities involved with AAV manufacturing for gene therapy. Kee shared his perspective on the resources, tools and expertise needed to scale up production, as well as how Tenaya is innovating and strategizing to overcome these challenges.Read More
Talent, culture, and ethics are all necessary ingredients in the biotech recipe for success
Our CEO, Faraz Ali, spoke with Peter Kaplan for an article in STAT to discuss the core values that are essential for a biotech company’s success. Faraz outlined the ways in which strong ethics and the right moral compass are crucial for creating a culture that empowers all employees. Our mission: find talented people who want to do the right thing.Read More
Join Our Team
Are you ambitious, driven, energized by scientific innovation and committed to making a difference for patients suffering from heart disease? Do you value a culture grounded in science and collaboration? Our team combines deep biological insights, sophisticated drug development technologies and a boundless determination to change the future for the millions of people affected by heart disease.